By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nordic Bioscience A/S 

Herlev Hovedgade 207

Herlev    2730  Denmark
Phone: 45-4452-5252 Fax: 45-4452-5251



Company News
Symic Biomedical Announces Collaboration With Nordic Bioscience A/S For Its Osteoarthritis Program 1/5/2015 8:55:30 AM
Enteris Biopharma and Nordic Bioscience A/S's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform 9/30/2013 10:03:48 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs 5/9/2013 10:09:25 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Announce Preliminary Selection of Lead Compound for Treating Type 2 Diabetes 8/16/2012 10:48:35 AM
Unigene Laboratories, Inc. (UGNE) to Host Live Conference Call and Webcast to Discuss Collaboration with Nordic Bioscience A/S and Formation of Joint Development Vehicle 10/6/2011 10:08:00 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Combine Industry Leading Capabilities to Advance Unigene's Proprietary Peptides through Phase 2 Proof-of-Concept for the Treatment of Type 2 Diabetes, Osteoarthritis and Osteoporosis 10/6/2011 9:54:50 AM
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT 7/23/2010 7:08:08 AM
NxStage Medical, Inc. (NXTM) and Nordic Medcom Sign Distribution Agreement for the System One(TM) 2/3/2010 6:32:29 AM
Manhattan Pharmaceuticals, Inc. (MHA) Announces Amendment of Joint Venture Deal With Nordic Biotech 6/13/2008 7:00:26 AM
Manhattan Pharmaceuticals, Inc. (MHA) Announces Closing of Joint Venture With Nordic Biotech 2/27/2008 6:22:10 AM